Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali

Background. In 2010, mass vaccination with a then-new meningococcal A polysaccharide–tetanus toxoid protein conjugate vaccine (PsA-TT, or MenAfriVac) was undertaken in 1- to 29-year-olds in Bamako, Mali. Whether vaccination with PsA-TT effectively boosts tetanus immunity in a population with heterog...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Infect Dis
मुख्य लेखकों: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Onwuchekwa, Uma, Dembélé, Awa Traoré Eps, Almond, Rachael, Frankland, Sarah, Patel, Sima, Wood, Daniel, Nascimento, Maria, Manigart, Olivier, Trotter, Caroline L., Greenwood, Brian, Sow, Samba O.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2015
विषय:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639490/
https://ncbi.nlm.nih.gov/pubmed/26553691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ513
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन